# Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever)

> **NCT00348361** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 48 (—)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Fluticasone Propionate

## Key facts

- **NCT ID:** NCT00348361
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 48 (—)
- **Last updated:** 2008-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00348361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00348361, "Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00348361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*